Bath & Body Works' Q2 Bottomline Beats Reflecting Cost Optimization & Margin Improvement Initiatives

Bath & Body Works Inc BBWI reported a second-quarter FY23 sales decline of 3.6% year-on-year to $1.56 billion, missing the analyst consensus of $1.57 billion.

Revenue from the U.S. and Canada stores decreased 1% Y/Y to $1.14 billion, International stores fell 4% to $86 million, while Direct sales declined 10% to $329 million.

Gross profit decreased 5.8% Y/Y to $622 million with a margin of 39.8%.

The operating margin was 12.1%, and operating income for the quarter rose 22.3% to $188 million.

Adjusted EPS of $0.40 beat the analyst consensus of $0.33.

Bath & Body Works held $790 million in cash and equivalents as of July 29, 2023. At the end of Q2, inventories declined 15.7% Y/Y to $818 million.

As of July 29, the company had 1,823 stores compared to 1,802 stores in January.

Outlook: Bath & Body Works sees Q3 FY23 EPS of $0.30-$0.40 versus the consensus of $0.37. It expects Q3 sales to decline 2.5% - 4%.

It sees FY23 FY23 sales to decline 1.5% - 3.5% (prior flat to mid-single-digit decline). It raised FY23 adjusted EPS guidance from $2.68 - $3.08 to $2.80 - $3.10, versus the consensus estimate of $2.99.

Price Action: BBWI shares are trading higher by 1.46% at $35.44 on the last check Wednesday.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsEquitiesNewsGuidanceMarketsGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!